# Inhaled NO as an Anti-inflammatory and Anti-reperfusion Agent in Infants and Children Undergoing Cardiopulmonary Bypass

> **NCT00585013** · PHASE1,PHASE2 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 17 (actual)

## Conditions studied

- Congenital Heart Disease

## Interventions

- **DRUG:** Nitric Oxide

## Key facts

- **NCT ID:** NCT00585013
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2015-11-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00585013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00585013, "Inhaled NO as an Anti-inflammatory and Anti-reperfusion Agent in Infants and Children Undergoing Cardiopulmonary Bypass". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00585013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*